On September 12, 2023 NanOlogy LLC, a clinical-stage oncology company, reported that two abstracts have been accepted for presentation at the ninth AACR (Free AACR Whitepaper) Special Conference in Cancer Research: Pancreatic Cancer on September 27-30 in Boston, Massachusetts (Press release, NanOlogy, SEP 12, 2023, View Source;utm_medium=rss&utm_campaign=nanology-announces-two-abstracts-have-been-accepted-for-presentation-at-aacr-special-conference-in-cancer-research-pancreatic-cancer [SID1234635105]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The first abstract (A048) entitled: "Enhancing the immune response in locally advanced pancreatic cancer (LAPC) with intratumoral endoscopic ultrasound-guided fine needle injection of large surface area microparticle paclitaxel." will be presented by Andrew Hendifar (Cedars-Sinai Medical Center, Los Angeles, California) during poster session A on September 27th from 7:25 PM to 9:00 PM.
The second abstract (B004) entitled: "EUS guided local administration of large surface area microparticle paclitaxel with neoadjuvant chemotherapy in locally advanced pancreatic cancer: A single center experience." will be presented by Harish Gopakumar (University of Illinois College of Medicine, Peoria, Illinois) during poster session B on September 28th from 4:40 PM to 6:30 PM.
A press release summarizing presentation data will be issued following the conference.